{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T05:06:44Z","timestamp":1789189604978,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":371,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA1100500"],"award-info":[{"award-number":["2021YFA1100500"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["92159202"],"award-info":[{"award-number":["92159202"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902407"],"award-info":[{"award-number":["81902407"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1111\/ajt.17124","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T23:34:44Z","timestamp":1655854484000},"page":"2323-2336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantation"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0846-5489","authenticated-orcid":false,"given":"Sunbin","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangjiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaonan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyang","family":"Que","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiongjie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lincheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianwei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renyi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongli","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangchen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1459-8261","authenticated-orcid":false,"given":"Shusen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2761-2811","authenticated-orcid":false,"given":"Xiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1111\/ajt.17124_bib1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell."},{"issue":"Suppl 1","key":"10.1111\/ajt.17124_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hep.31310","article-title":"Role of the mammalian target of rapamycin pathway in liver cancer: from molecular genetics to targeted therapies","volume":"73","author":"Lu","year":"2021","journal-title":"Hepatology."},{"issue":"1","key":"10.1111\/ajt.17124_bib3","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13045-019-0754-1","article-title":"Targeting mTOR for cancer therapy","volume":"12","author":"Hua","year":"2019","journal-title":"J Hematol Oncol."},{"issue":"8","key":"10.1111\/ajt.17124_bib4","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/annonc\/mdx268","article-title":"Everolimus with paclitaxel and carboplatin as first-line treatment for metastatic large-cell neuroendocrine lung carcinoma: a multicenter phase II trial","volume":"28","author":"Christopoulos","year":"2017","journal-title":"Ann Oncol."},{"issue":"14","key":"10.1111\/ajt.17124_bib5","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1200\/JCO.2014.56.2082","article-title":"Multicenter phase II trial of temsirolimus and bevacizumab in pancreatic neuroendocrine tumors","volume":"33","author":"Hobday","year":"2015","journal-title":"J Clin Oncol."},{"issue":"2","key":"10.1111\/ajt.17124_bib6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.eururo.2021.03.015","article-title":"A single-arm, multicenter, phase 2 study of lenvatinib plus everolimus in patients with advanced non-clear cell renal cell carcinoma","volume":"80","author":"Hutson","year":"2021","journal-title":"Eur Urol."},{"issue":"14","key":"10.1111\/ajt.17124_bib7","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1200\/JCO.2015.64.8808","article-title":"Randomized open-label phase II trial of apitolisib (GDC-0980), a novel inhibitor of the PI3K\/mammalian target of rapamycin pathway, versus everolimus in patients with metastatic renal cell carcinoma","volume":"34","author":"Powles","year":"2016","journal-title":"J Clin Oncol."},{"issue":"1","key":"10.1111\/ajt.17124_bib8","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin."},{"issue":"6","key":"10.1111\/ajt.17124_bib9","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/lt.24758","article-title":"Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: an attempt to perform an ideal meta-analysis","volume":"23","author":"Menahem","year":"2017","journal-title":"Liver Transpl."},{"issue":"5","key":"10.1111\/ajt.17124_bib10","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/SLA.0000000000004280","article-title":"mTOR inhibition is most beneficial after liver transplantation for hepatocellular carcinoma in patients with active tumors","volume":"272","author":"Schnitzbauer","year":"2020","journal-title":"Ann Surg."},{"issue":"4","key":"10.1111\/ajt.17124_bib11","doi-asserted-by":"crossref","first-page":"80","DOI":"10.21037\/atm.2020.01.10","article-title":"Sirolimus-based immunosuppression improves outcomes in liver transplantation recipients with hepatocellular carcinoma beyond the Hangzhou criteria","volume":"8","author":"Ling","year":"2020","journal-title":"Ann Transl Med."},{"issue":"1","key":"10.1111\/ajt.17124_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol Cancer."},{"issue":"45","key":"10.1111\/ajt.17124_bib13","doi-asserted-by":"crossref","first-page":"27698","DOI":"10.18632\/oncotarget.25498","article-title":"PKM2 under hypoxic environment causes resistance to mTOR inhibitor in human castration resistant prostate cancer","volume":"9","author":"Yasumizu","year":"2018","journal-title":"Oncotarget."},{"issue":"4","key":"10.1111\/ajt.17124_bib14","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/cdd.2008.21","article-title":"The role of hypoxia-inducible factors in tumorigenesis","volume":"15","author":"Rankin","year":"2008","journal-title":"Cell Death Differ."},{"issue":"7","key":"10.1111\/ajt.17124_bib15","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/gutjnl-2019-319616","article-title":"USP22 promotes hypoxia-induced hepatocellular carcinoma stemness by a HIF1alpha\/USP22 positive feedback loop upon TP53 inactivation","volume":"69","author":"Ling","year":"2020","journal-title":"Gut."},{"issue":"6104","key":"10.1111\/ajt.17124_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1126\/science.1226344","article-title":"Genome sequencing identifies a basis for everolimus sensitivity","volume":"338","author":"Iyer","year":"2012","journal-title":"Science."},{"issue":"8","key":"10.1111\/ajt.17124_bib17","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1136\/gutjnl-2016-312734","article-title":"TSC1\/2 mutations define a molecular subset of HCC with aggressive behaviour and treatment implication","volume":"66","author":"Ho","year":"2017","journal-title":"Gut."},{"issue":"5","key":"10.1111\/ajt.17124_bib18","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1158\/1535-7163.MCT-14-0768","article-title":"Loss of tuberous sclerosis complex 2 (TSC2) is frequent in hepatocellular carcinoma and predicts response to mtorc1 inhibitor everolimus","volume":"14","author":"Huynh","year":"2015","journal-title":"Mol Cancer Ther."},{"issue":"9","key":"10.1111\/ajt.17124_bib19","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/adma.201504288","article-title":"Fusogenic reactive oxygen species triggered charge-reversal vector for effective gene delivery","volume":"28","author":"Liu","year":"2016","journal-title":"Adv Mater."},{"issue":"8","key":"10.1111\/ajt.17124_bib20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia."},{"issue":"269","key":"10.1111\/ajt.17124_bib21","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal."},{"issue":"19","key":"10.1111\/ajt.17124_bib22","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1038\/emboj.2012.231","article-title":"E2F7 and E2F8 promote angiogenesis through transcriptional activation of VEGFA in cooperation with HIF1","volume":"31","author":"Weijts","year":"2012","journal-title":"EMBO J."},{"issue":"1","key":"10.1111\/ajt.17124_bib23","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/s41467-020-15795-8","article-title":"Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT\/mTOR\/HIF1alpha pathway suppression","volume":"11","author":"Weng","year":"2020","journal-title":"Nat Commun."},{"issue":"4","key":"10.1111\/ajt.17124_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12032-017-0917-2","article-title":"New concepts in embolotherapy of HCC","volume":"34","author":"Pesapane","year":"2017","journal-title":"Med Oncol."},{"issue":"14","key":"10.1111\/ajt.17124_bib25","doi-asserted-by":"crossref","first-page":"7716","DOI":"10.1093\/nar\/gkz587","article-title":"An E2F7-dependent transcriptional program modulates DNA damage repair and genomic stability","volume":"47","author":"Mitxelena","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1111\/ajt.17124_bib26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s13046-018-0927-8","article-title":"MicroRNA-302a\/d inhibits the self-renewal capability and cell cycle entry of liver cancer stem cells by targeting the E2F7\/AKT axis","volume":"37","author":"Ma","year":"2018","journal-title":"J Exp Clin Cancer Res."},{"issue":"1","key":"10.1111\/ajt.17124_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/hep.31259","article-title":"E2F7 is a potent inhibitor of liver tumor growth in adult mice","volume":"73","author":"Moreno","year":"2021","journal-title":"Hepatology."},{"issue":"12","key":"10.1111\/ajt.17124_bib28","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1136\/gutjnl-2016-313264","article-title":"SENP1 promotes hypoxia-induced cancer stemness by HIF-1alpha deSUMOylation and SENP1\/HIF-1alpha positive feedback loop","volume":"66","author":"Cui","year":"2017","journal-title":"Gut."},{"issue":"3","key":"10.1111\/ajt.17124_bib29","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.21037\/jgo-20-378","article-title":"TSC1\/2 mutations-a unique type of mutation suitable for liver transplantation of Hepatocellular carcinoma","volume":"12","author":"Wei","year":"2021","journal-title":"J Gastrointest Oncol."},{"issue":"10","key":"10.1111\/ajt.17124_bib30","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1016\/j.ejso.2021.04.001","article-title":"Sirolimus-based immunosuppression improves the prognosis of liver transplantation recipients with low TSC1\/2 expression in hepatocellular carcinoma beyond the Milan criteria","volume":"47","author":"Ye","year":"2021","journal-title":"Eur J Surg Oncol."},{"issue":"2","key":"10.1111\/ajt.17124_bib31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.hbpd.2021.09.001","article-title":"Efficacy and safety of sirolimus early conversion protocol in liver transplant patients with hepatocellular carcinoma: a single-arm, multicenter, prospective study","volume":"21","author":"Su","year":"2022","journal-title":"Hepatobiliary Pancreat Dis Int."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.17124","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.17124","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522299377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522299377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.17124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:38:41Z","timestamp":1761629921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522299377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1600613522299377"],"URL":"https:\/\/doi.org\/10.1111\/ajt.17124","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"E2F7 promotes mammalian target of rapamycin inhibitor resistance in hepatocellular carcinoma after liver transplantation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.17124","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}